Analyse de l'application Post-MI pour le 17 février

Application for use by patients who have recently undergone heart procedures.   Currently, the users are patients who take part of an approved clinical trial conducted in the Department of Medicine, The University of Hong Kong, Queen Mary Hospital in Hong Kong. They will be using the mobile application along with our hardware and AI solutions to monitor their cardiac health. To be used along with the Comfit Boomerang single lead ECG recoding hardware device.  Enables researcher-physicians to remotely track user's relevant vitals and heart function. Provides patients with support for post operative recovery by reminding them of their lifestyle goals and medication schedules as prescribed by their physicians. Connects and shares data with the Comfit dashboard web application to be used by respective clinicians to view and analyse data collected from the app.